arrow_back Trending Legislation
Share share

Enhanced Early Cancer Screening for Breast and Cervical Cancers

This act aims to strengthen the early detection program for breast and cervical cancers, ensuring better access to screening and diagnostic services. Citizens can expect increased support for prevention and quicker access to necessary medical services, potentially improving treatment outcomes and reducing health disparities.
Key points
Increases funding for breast and cervical cancer early detection programs to $275 million annually through 2029.
Introduces new support activities like patient navigation and evidence-based strategies to boost screening rates.
Focuses on reducing disparities in cancer incidence and deaths among populations with higher rates.
Improves access to screening and diagnostic services by addressing related barriers.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
SCREENS for Cancer Act of 2024
Print number: HR 3916
Sponsor: Rep. Morelle, Joseph D. [D-NY-25]
Process start date: 2023-06-07
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Enhanced Early Cancer Screening for Breast and Cervical Cancers

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 3916.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-06-07.

What are the main provisions?

Key points include:

  • Increases funding for breast and cervical cancer early detection programs to $275 million annually through 2029.
  • Introduces new support activities like patient navigation and evidence-based strategies to boost screening rates.
  • Focuses on reducing disparities in cancer incidence and deaths among populations with higher rates.
  • Improves access to screening and diagnostic services by addressing related barriers.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Morelle, Joseph D. [D-NY-25].

What is the latest detailed status?

The latest detailed status is: Placed on the Union Calendar, Calendar No. 437.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

Analysis and Potential Impact of HR 3916

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health